FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40993411000001101: Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2446841000001110 Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2446851000001113 Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) Is a Lidocaine 200mg/10ml (2%) solution for injection ampoules true Inferred relationship Existential restriction modifier
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) 20 ampoule Has AMP True Lidocaine 200mg/10ml (2%) solution for injection ampoules (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start